You have 9 free searches left this month | for more free features.

Depressive Disorder, Treatment-Resistant

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Depressive Disorder, Treatment-Resistant Trial in Saint Louis (tDCS)

Active, not recruiting
  • Depressive Disorder, Treatment-Resistant
  • tDCS
  • Saint Louis, Missouri
    Washington University in Saint Louis
Jul 27, 2022

Depressive Disorder, Treatment-Resistant Trial in Kaohsiung (iTBS-1800, iTBS-1200)

Active, not recruiting
  • Depressive Disorder, Treatment-Resistant
  • iTBS-1800
  • iTBS-1200
  • Kaohsiung, Taiwan
    ChangGungMH
May 20, 2022

Depressive Disorder, Treatment-Resistant Trial (Psilocybin-assisted psychotherapy)

Not yet recruiting
  • Depressive Disorder, Treatment-Resistant
  • Psilocybin-assisted psychotherapy
  • (no location specified)
Oct 12, 2022

Belief Updating in Treatment Resistant Depression

Not yet recruiting
  • Treatment Resistant Depression
  • functional magnetic resonance imaging
  • (no location specified)
Oct 10, 2022

Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant Trial in Saint Louis (Nitrous Oxide 25%, Nitrous Oxide 50%,

Completed
  • Depressive Disorder, Major
  • Depressive Disorder, Treatment-Resistant
  • Nitrous Oxide 25%
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 28, 2022

Deep Brain Stimulation for Treatment-Resistant Depression

Active, not recruiting
  • Treatment Resistant Depression
  • +2 more
  • SCC DBS
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Feb 22, 2022

MDD Trial (iTBS)

Not yet recruiting
  • Major Depressive Disorder
  • iTBS
  • (no location specified)
Oct 13, 2022

Treatment-resistant Depression, MDD Trial in Taipei (Prolonged intermittent theta burst stimulation (piTBS), 20Hz rTMS, sham

Recruiting
  • Treatment-resistant Depression
  • Major Depressive Disorder
  • Prolonged intermittent theta burst stimulation (piTBS)
  • +2 more
  • Taipei, Taiwan
    Taipei Veterans General Hospital, Taiwan
Aug 15, 2022

Treatment-resistant Depression, MDD Trial in Taipei city (Midazolam (active ), Ketamine and Midazolam (active ), Ketamine)

Recruiting
  • Treatment-resistant Depression
  • Major Depressive Disorder
  • Midazolam (active placebo)
  • +2 more
  • Taipei city, Taiwan
    Taipei Veterans General Hospital, Taiwan
Apr 1, 2022

Treatment Resistant Depression, MDD Trial in Toronto (Bupivacaine Hydrochloride, Normal Saline)

Completed
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Bupivacaine Hydrochloride
  • Normal Saline
  • Toronto, Ontario, Canada
    St. Michael's Hospital
May 27, 2022

MDD, Treatment Resistant Depression Trial in Houston (Deep Brain Stimulation Model 3387 Model 3389)

Recruiting
  • Major Depressive Disorder
  • Treatment Resistant Depression
  • Deep Brain Stimulation Model 3387 Model 3389
  • Houston, Texas
    UT Center of Excellence on Mood Disorders
Feb 4, 2022

MDD, Treatment-Resistant Depression, Depression Trial run by the NIMH (Placebo, TS-161 (50 - 100 mg))

Recruiting
  • Major Depressive Disorder
  • +2 more
  • Placebo
  • TS-161 (50 - 100 mg)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Treatment Resistant Depression, MDD Trial in Innsbruck (Esketamine nasal spray, Electroconvulsive therapy)

Withdrawn
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Esketamine nasal spray
  • Electroconvulsive therapy
  • Innsbruck, Tyrol, Austria
    Medical University Innsbruck
Aug 2, 2022

Depressive Disorder, Treatment-Resistant Trial in Oxford (Ebselen, Placebo)

Recruiting
  • Depressive Disorder, Treatment-Resistant
  • Oxford, Oxfordshire, United Kingdom
    Neurosciences Building, Dept. Psychiatry, Warneford Hospital
Dec 15, 2021

Depressive Disorder, Treatment-Resistant Trial in Saint Louis (Ketamine, Clonidine, )

Active, not recruiting
  • Depressive Disorder, Treatment-Resistant
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 30, 2021

Treatment Resistant Depressive Disorder Trial in Houston (Ketamine, Midazolam)

Completed
  • Treatment Resistant Depressive Disorder
  • Houston, Texas
    Michael E. DeBakey VA Medical Center, Houston, TX
Dec 15, 2021

Resistant Depression, Treatment Trial in Vitoria Gasteiz (Concurrent training)

Recruiting
  • Resistant Depression, Treatment
  • Concurrent training
  • Vitoria Gasteiz, Spain
    Basque Country University
Nov 24, 2021

Treatment Resistant Depression, MDD, Depression Trial in Maastricht (5 Methoxy N,N Dimethyltryptamine)

Completed
  • Treatment Resistant Depression
  • +2 more
  • 5 Methoxy N,N Dimethyltryptamine
  • Maastricht, Netherlands
    Clinical Trial Site
Dec 6, 2021

Depression Severe Trial in Saint Louis (INTRACALVARIAL PREFRONTAL CORTICAL STIMULATION (IpCS) IN SEVERE TREATMENT-RESISTANT

Not yet recruiting
  • Depression Severe
  • INTRACALVARIAL PREFRONTAL CORTICAL STIMULATION (IpCS) IN SEVERE TREATMENT-RESISTANT DEPRESSION
  • Saint Louis, Missouri
    Washington University in St Louis School of Medicine
May 23, 2022

Treatment Resistant Depression Trial in Pittsburgh (Amygdala Neurofeedback, Parietal Neurofeedback)

Recruiting
  • Treatment Resistant Depression
  • Amygdala Neurofeedback
  • Parietal Neurofeedback
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Jan 5, 2022

Treatment Resistant Depression, MDD, Bipolar Disorder Trial in Halifax (Ketamine, Midazolam)

Not yet recruiting
  • Treatment Resistant Depression
  • +2 more
  • Halifax, Nova Scotia, Canada
    Mood Disorders Program
Nov 15, 2022

Depressive Disorder, Treatment-Resistant, Depressive Disorder, Major Trial in Shanghai (Sevoflurane, Placebo)

Not yet recruiting
  • Depressive Disorder, Treatment-Resistant
  • Depressive Disorder, Major
  • Shanghai, Shanghai, China
    Shanghai First Maternity and Infant Hospital, Tongji University
Aug 12, 2021

Depressive Disorder, Treatment-Resistant Trial in London (Naltrexone, Placebo, Ketamine)

Recruiting
  • Depressive Disorder, Treatment-Resistant
  • London, United Kingdom
    King's College London
Sep 28, 2021

Depression, Unipolar, Treatment Resistant Depression Trial in Oxford (PF-04995274, Placebo Oral Tablet)

Recruiting
  • Depression, Unipolar
  • Treatment Resistant Depression
  • Oxford, Oxfordshire, United Kingdom
    University of Oxford
Jul 22, 2022

Treatment Resistant Depression Trial in Mississauga (Psilocybin)

Active, not recruiting
  • Treatment Resistant Depression
  • Mississauga, Ontario, Canada
    Canadian Rapid Treatment Centre of Excellence (CRTCE)
Mar 2, 2022